Publication Month: Mar 2022 | Report Code: TIPHE100000821 | No. of Pages: 157 | Category: Healthcare IT | Status: Published
Mobile health (mHealth) is a technique that includes the use of mobile commination devices, such as mobile phones, tablets, personal digital assistants (PDAs), and other wireless devices for distributing health services and information. mHealth unlocks new opportunities for improving the monitoring of chronic conditions and helps in developing the prevention and treatment of remote patients`. mHealth enables healthcare providers to offer consultation services, care management, diagnosis, and self-management services by using information & communication technologies (ICT). It involves a wide variety of technologies and tactics to deliver virtual medical, health, and education services to users. mHealth is also a collection of means that can be used to enhance educational services. It includes instruments, apparatus, machines, or software (including mobile applications) that are involved in the delivery of healthcare services. The increasing adoption of smartphones and other mobile platforms, and the exponential spread of COVID-19 contribute to the market progress. Further, growing awareness regarding mHealth and rising government funding for the development and adoption of virtual medical platforms are likely to foster the mHealth market growth during the forecast period. However, security and privacy issues restrict the market growth.
|Market Size Value in||US$ 70.83 Billion in 2021|
|Market Size Value by||US$ 410.39 Billion by 2028|
|Growth rate||CAGR of 28.5% from 2021 to 2028|
|No. of Pages||157|
|No. of Tables||93|
|No. of Charts & Figures||165|
|Historical data available||Yes|
|Segments covered||Service, Devices, End User, and Geography|
|Regional scope||North America, Europe, Asia Pacific, Middle East & Africa, South & Central America|
|Country scope||US, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina|
|Report coverage||Revenue forecast, company ranking, competitive landscape, growth factors, and trends|
|Free Sample Copy Available|
The mHealth market in the Asia Pacific is expected to grow at the fastest CAGR during the forecast period due to the rise in prevalence of various diseases and conditions, along with the significant increase in population. China, India, Australia, and Japan are expected to be the major contributors to the regional market growth.
The COVID-19 outbreak has become a threat to public health. Various emergency actions were taken by country governments to limit the spread of this disease; of these, the COVAX initiative by World Health Organization (WHO) was aggressively enacted. Vaccination against COVID-19 has been made mandatory for people across the world. Moreover, governments in different countries have instructed their travel and tourism departments to thoroughly check the vaccination status of travelers coming to the respective countries.
Telemedicine is a rapidly expanding field of medicine and an alternative method for delivering quality medical care to patients, who now have various healthcare services at their fingertips. With the COVID-19 pandemic, there has been an increase in the use of telemedicine to connect patients and healthcare providers, which has been made possible by mobile health (mHealth) applications. The vigorous growth of mobile technologies has paved the way for the proliferation of mHealth; there is increasing evidence from WHO that suggests mHealth has improved patient lives, especially during the COVID-19 pandemic, as a majority of the population was reluctant to step out of their quarantine facilities and homes for any need. Moreover, the possible cost-effectiveness of medical practices for consumers/patients contributes to the mHealth market growth.
The mHealth market, by device, is segmented into insulin pump, BP monitor, glucose monitor, personal pulse oximeter, and other devices. The insulin pump segment held the largest share of the market in 2021. However, the personal pulse oximeter segment is anticipated to register the highest CAGR in the market during the forecast period.
By service, the mHealth market is segmented into remote monitoring, diagnosis, treatment, health support, fitness & wellness, and other services. The remote monitoring services segment held the largest share of the market in 2021 and is anticipated to register the highest CAGR in the market during the forecast period. Health remote monitoring systems (HRMS) benefit by assist in the reduction of patient load at hospitals and health centers. Patients that would most benefit from HRMS amid the COVID-19 pandemic are those with chronic diseases, older adults, and patients that experience less severe symptoms recovering from SARS-CoV-2 infection.